Publications from OUS - Experimental Immunotherapy (Olweus)

45 publications found

Publications 2019

  1. Ali M, Foldvari Z, Giannakopoulou E, Böschen ML, Strønen E, Yang W, Toebes M, Schubert B, Kohlbacher O, Schumacher TN, Olweus J (2019)
    Induction of neoantigen-reactive T cells from healthy donors
    Nat Protoc, 14 (6), 1926-1943
    DOI 10.1038/s41596-019-0170-6, PubMed 31101906
  2. Olweus J, Lund-Johansen F (2019)
    Finding Neo (antigens, that is)
    Blood, 134 (2), 108-109
    DOI 10.1182/blood.2019001334, PubMed 31296544

Publications 2018

  1. Oei VYS, Siernicka M, Graczyk-Jarzynka A, Hoel HJ, Yang W, Palacios D, Almåsbak H, Bajor M, Clement D, Brandt L, Önfelt B, Goodridge J, Winiarska M, Zagozdzon R, Olweus J, Kyte JA, Malmberg KJ (2018)
    Intrinsic Functional Potential of NK-Cell Subsets Constrains Retargeting Driven by Chimeric Antigen Receptors
    Cancer Immunol Res, 6 (4), 467-480
    DOI 10.1158/2326-6066.CIR-17-0207, PubMed 29459477

Publications 2017

  1. Jha SK, Rauniyar K, Karpanen T, Leppänen VM, Brouillard P, Vikkula M, Alitalo K, Jeltsch M (2017)
    Efficient activation of the lymphangiogenic growth factor VEGF-C requires the C-terminal domain of VEGF-C and the N-terminal domain of CCBE1
    Sci Rep, 7 (1), 4916
    DOI 10.1038/s41598-017-04982-1, PubMed 28687807
  2. Karpanen T, Olweus J (2017)
    The Potential of Donor T-Cell Repertoires in Neoantigen-Targeted Cancer Immunotherapy
    Front Immunol, 8, 1718
    DOI 10.3389/fimmu.2017.01718, PubMed 29321773
  3. Olweus J (2017)
    Manufacture of CAR-T cells in the body
    Nat Biotechnol, 35 (6), 520-521
    DOI 10.1038/nbt.3898, PubMed 28591119
  4. Reiseter S, Gunnarsson R, Corander J, Haydon J, Lund MB, Aaløkken TM, Taraldsrud E, Hetlevik SO, Molberg Ø (2017)
    Disease evolution in mixed connective tissue disease: results from a long-term nationwide prospective cohort study
    Arthritis Res Ther, 19 (1), 284
    DOI 10.1186/s13075-017-1494-7, PubMed 29268795
  5. Stuchlý J, Kanderová V, Vlková M, Heřmanová I, Slámová L, Pelák O, Taraldsrud E, Jílek D, Králíc Ková P, Fevang B, Trková M, Hrušák O, Froňková E, Šedivá A, Litzman J, Kalina T (2017)
    Common Variable Immunodeficiency patients with a phenotypic profile of immunosenescence present with thrombocytopenia
    Sci Rep, 7, 39710
    DOI 10.1038/srep39710, PubMed 28054583
  6. Taraldsrud E, Fevang B, Jørgensen SF, Moltu K, Hilden V, Taskén K, Aukrust P, Myklebust JH, Olweus J (2017)
    Defective IL-4 signaling in T cells defines severe common variable immunodeficiency
    J Autoimmun, 81, 110-119
    DOI 10.1016/j.jaut.2017.04.004, PubMed 28476239

Publications 2016

  1. Mensali N, Ying F, Sheng VO, Yang W, Walseng E, Kumari S, Fallang LE, Kolstad A, Uckert W, Malmberg KJ, Wälchli S, Olweus J (2016)
    Targeting B-cell neoplasia with T-cell receptors recognizing a CD20-derived peptide on patient-specific HLA
    Oncoimmunology, 5 (5), e1138199
    DOI 10.1080/2162402X.2016.1138199, PubMed 27467957
  2. Strønen E, Toebes M, Kelderman S, van Buuren MM, Yang W, van Rooij N, Donia M, Böschen ML, Lund-Johansen F, Olweus J, Schumacher TN (2016)
    Targeting of cancer neoantigens with donor-derived T cell receptor repertoires
    Science, 352 (6291), 1337-41
    DOI 10.1126/science.aaf2288, PubMed 27198675
  3. Taraldsrud E, Aukrust P, Jørgensen S, Lingjærde OC, Olweus J, Myklebust JH, Fevang B (2016)
    Patterns of constitutively phosphorylated kinases in B cells are associated with disease severity in common variable immunodeficiency
    Clin Immunol, 175, 69-74
    DOI 10.1016/j.clim.2016.11.014, PubMed 27919819

Publications 2015

  1. Almåsbak H, Walseng E, Kristian A, Myhre MR, Suso EM, Munthe LA, Andersen JT, Wang MY, Kvalheim G, Gaudernack G, Kyte JA (2015)
    Inclusion of an IgG1-Fc spacer abrogates efficacy of CD19 CAR T cells in a xenograft mouse model
    Gene Ther, 22 (5), 391-403
    DOI 10.1038/gt.2015.4, PubMed 25652098
  2. Karpanen T, Olweus J (2015)
    T-cell receptor gene therapy--ready to go viral?
    Mol Oncol, 9 (10), 2019-42
    DOI 10.1016/j.molonc.2015.10.006, PubMed 26548533
  3. Kolstad A, Olweus J (2015)
    "In situ" vaccination for systemic effects in follicular lymphoma
    Oncoimmunology, 4 (7), e1014773
    DOI 10.1080/2162402X.2015.1014773, PubMed 26140239
  4. Liaskou E, Klemsdal Henriksen EK, Holm K, Kaveh F, Hamm D, Fear J, Viken MK, Hov JR, Melum E, Robins H, Olweus J, Karlsen TH, Hirschfield GM (2015)
    High-throughput T-cell receptor sequencing across chronic liver diseases reveals distinct disease-associated repertoires
    Hepatology, 63 (5), 1608-19
    DOI 10.1002/hep.28116, PubMed 26257205
  5. Olweus J (2015)
    Cancer immunotherapy--Converting immune failure to clinical response
    Mol Oncol, 9 (10), 1891-3
    DOI 10.1016/j.molonc.2015.10.017, PubMed 26563645
  6. Tadesse FG, Mensali N, Fallang LE, Walseng E, Yang W, Olweus J, Wälchli S (2015)
    Unpredicted phenotypes of two mutants of the TcR DMF5
    J Immunol Methods, 425, 37-44
    DOI 10.1016/j.jim.2015.06.006, PubMed 26079729
  7. Walseng E, Wälchli S, Fallang LE, Yang W, Vefferstad A, Areffard A, Olweus J (2015)
    Soluble T-cell receptors produced in human cells for targeted delivery
    PLoS One, 10 (4), e0119559
    DOI 10.1371/journal.pone.0119559, PubMed 25875651

Publications 2014

  1. Anttonen T, Belevich I, Kirjavainen A, Laos M, Brakebusch C, Jokitalo E, Pirvola U (2014)
    How to bury the dead: elimination of apoptotic hair cells from the hearing organ of the mouse
    J Assoc Res Otolaryngol, 15 (6), 975-92
    DOI 10.1007/s10162-014-0480-x, PubMed 25074370
  2. Haugaa H, Taraldsrud E, Nyrerød HC, Tønnessen TI, Foss A, Solheim BG (2014)
    Low incidence of hyperfibrinolysis and thromboembolism in 195 primary liver transplantations transfused with solvent/detergent-treated plasma
    Clin Med Res, 12 (1-2), 27-32
    DOI 10.3121/cmr.2013.1168, PubMed 24415744
  3. Lossius A, Johansen JN, Vartdal F, Robins H, Jūratė Šaltytė B, Holmøy T, Olweus J (2014)
    High-throughput sequencing of TCR repertoires in multiple sclerosis reveals intrathecal enrichment of EBV-reactive CD8+ T cells
    Eur J Immunol, 44 (11), 3439-52
    DOI 10.1002/eji.201444662, PubMed 25103993
  4. Taraldsrud E, Fevang B, Aukrust P, Beiske KH, Fløisand Y, Frøland S, Rollag H, Olweus J (2014)
    Common variable immunodeficiency revisited: normal generation of naturally occurring dendritic cells that respond to Toll-like receptors 7 and 9
    Clin Exp Immunol, 175 (3), 439-48
    DOI 10.1111/cei.12239, PubMed 24237110

Publications 2013

  1. Dollner R, Taraldsrud E, Iversen K, Osnes T, Kristensen B, Kramer MF (2013)
    Non-allergic, mastocytosis-associated rhinitis
    Clin Exp Allergy, 43 (4), 406-12
    DOI 10.1111/cea.12053, PubMed 23517036
  2. Fedorova M, Bollineni RC, Hoffmann R (2013)
    Protein carbonylation as a major hallmark of oxidative damage: update of analytical strategies
    Mass Spectrom Rev, 33 (2), 79-97
    DOI 10.1002/mas.21381, PubMed 23832618
  3. Kumari S, Wälchli S, Fallang LE, Yang W, Lund-Johansen F, Schumacher TN, Olweus J (2013)
    Alloreactive cytotoxic T cells provide means to decipher the immunopeptidome and reveal a plethora of tumor-associated self-epitopes
    Proc Natl Acad Sci U S A, 111 (1), 403-8
    DOI 10.1073/pnas.1306549111, PubMed 24344295
  4. Poczai P, Varga I, Laos M, Cseh A, Bell N, Valkonen JP, Hyvönen J (2013)
    Advances in plant gene-targeted and functional markers: a review
    Plant Methods, 9 (1), 6
    DOI 10.1186/1746-4811-9-6, PubMed 23406322
  5. Wälchli S, Kumari S, Fallang LE, Sand KM, Yang W, Landsverk OJ, Bakke O, Olweus J, Gregers TF (2013)
    Invariant chain as a vehicle to load antigenic peptides on human MHC class I for cytotoxic T-cell activation
    Eur J Immunol, 44 (3), 774-84
    DOI 10.1002/eji.201343671, PubMed 24293164

Publications 2012

  1. Anttonen T, Kirjavainen A, Belevich I, Laos M, Richardson WD, Jokitalo E, Brakebusch C, Pirvola U (2012)
    Cdc42-dependent structural development of auditory supporting cells is required for wound healing at adulthood
    Sci Rep, 2, 978
    DOI 10.1038/srep00978, PubMed 23248743
  2. Banik D, Khan AN, Walseng E, Segal BH, Abrams SI (2012)
    Interferon regulatory factor-8 is important for histone deacetylase inhibitor-mediated antitumor activity
    PLoS One, 7 (9), e45422
    DOI 10.1371/journal.pone.0045422, PubMed 23028998
  3. Huse K, Bakkebø M, Wälchli S, Oksvold MP, Hilden VI, Forfang L, Bredahl ML, Liestøl K, Alizadeh AA, Smeland EB, Myklebust JH (2012)
    Role of Smad proteins in resistance to BMP-induced growth inhibition in B-cell lymphoma
    PLoS One, 7 (10), e46117
    DOI 10.1371/journal.pone.0046117, PubMed 23049692
  4. Olweus J, Kolstad A (2012)
    [Can the immune system target cancer?]
    Tidsskr Nor Laegeforen, 132 (7), 784-5
    DOI 10.4045/tidsskr.12.0156, PubMed 22511078
  5. Zhen Y, Sørensen V, Skjerpen CS, Haugsten EM, Jin Y, Wälchli S, Olsnes S, Wiedlocha A (2012)
    Nuclear import of exogenous FGF1 requires the ER-protein LRRC59 and the importins Kpnα1 and Kpnβ1
    Traffic, 13 (5), 650-64
    DOI 10.1111/j.1600-0854.2012.01341.x, PubMed 22321063

Publications 2011

  1. Abrahamsen IW, Kjellevoll S, Greve-Isdahl M, Mensali N, Wälchli S, Kumari S, Loland BF, Egeland T, Kolstad A, Olweus J (2011)
    T cells raised against allogeneic HLA-A2/CD20 kill primary follicular lymphoma and acute lymphoblastic leukemia cells
    Int J Cancer, 130 (8), 1821-32
    DOI 10.1002/ijc.26209, PubMed 21630262
  2. Sokołowska I, Wälchli S, Węgrzyn G, Sandvig K, Słomińska-Wojewódzka M (2011)
    A single point mutation in ricin A-chain increases toxin degradation and inhibits EDEM1-dependent ER retrotranslocation
    Biochem J, 436 (2), 371-85
    DOI 10.1042/BJ20101493, PubMed 21388347
  3. Wälchli S, Løset GÅ, Kumari S, Johansen JN, Yang W, Sandlie I, Olweus J (2011)
    A practical approach to T-cell receptor cloning and expression
    PLoS One, 6 (11), e27930
    DOI 10.1371/journal.pone.0027930, PubMed 22132171

Publications 2010

  1. Abrahamsen IW, Stronen E, Wälchli S, Johansen JN, Kjellevoll S, Kumari S, Komada M, Gaudernack G, Tjonnfjord G, Toebes M, Schumacher TN, Lund-Johansen F, Olweus J (2010)
    Targeting B cell leukemia with highly specific allogeneic T cells with a public recognition motif
    Leukemia, 24 (11), 1901-9
    DOI 10.1038/leu.2010.186, PubMed 20844564
  2. Almåsbak H, Rian E, Hoel HJ, Pulè M, Wälchli S, Kvalheim G, Gaudernack G, Rasmussen AM (2010)
    Transiently redirected T cells for adoptive transfer
    Cytotherapy, 13 (5), 629-40
    DOI 10.3109/14653249.2010.542461, PubMed 21174490
  3. Sanner H, Kirkhus E, Merckoll E, Tollisen A, Røisland M, Lie BA, Taraldsrud E, Gran JT, Flatø B (2010)
    Long-term muscular outcome and predisposing and prognostic factors in juvenile dermatomyositis: A case-control study
    Arthritis Care Res (Hoboken), 62 (8), 1103-11
    DOI 10.1002/acr.20203, PubMed 20506141
  4. Yamazaki T, Wälchli S, Fujita T, Ryser S, Hoshijima M, Schlegel W, Kuroda S, Maturana AD (2010)
    Splice variants of enigma homolog, differentially expressed during heart development, promote or prevent hypertrophy
    Cardiovasc Res, 86 (3), 374-82
    DOI 10.1093/cvr/cvq023, PubMed 20097676

Publications 2009

  1. Gran JT, Molberg Ø, Dobloug GC, Andersson H, Taraldsrud E, Scheie D (2009)
    [Myositis-specific autoantibodies]
    Tidsskr Nor Laegeforen, 129 (16), 1631-4
    DOI 10.4045/tidsskr.09.35501, PubMed 19721478
  2. Rölle A, Olweus J (2009)
    Dendritic cells in cytomegalovirus infection: viral evasion and host countermeasures
    APMIS, 117 (5-6), 413-26
    DOI 10.1111/j.1600-0463.2009.02449.x, PubMed 19400865
  3. Stronen E, Abrahamsen IW, Gaudernack G, Wälchli S, Munthe E, Buus S, Johansen FE, Lund-Johansen F, Olweus J (2009)
    Dendritic cells engineered to express defined allo-HLA peptide complexes induce antigen-specific cytotoxic T cells efficiently killing tumour cells
    Scand J Immunol, 69 (4), 319-28
    DOI 10.1111/j.1365-3083.2008.02223.x, PubMed 19284496

Publications 2007

  1. Borresen P, Taraldsrud E, Berentsen SA (2007)
    [A three-year-old boy with bullous skin eruptions and paresis]
    Tidsskr Nor Laegeforen, 127 (15), 1950-2
    PubMed 17708060

Publications 2006

  1. Lunde K, Solheim S, Aakhus S, Arnesen H, Abdelnoor M, Egeland T, Endresen K, Ilebekk A, Mangschau A, Fjeld JG, Smith HJ, Taraldsrud E, Grøgaard HK, Bjørnerheim R, Brekke M, Müller C, Hopp E, Ragnarsson A, Brinchmann JE, Forfang K (2006)
    Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction
    N Engl J Med, 355 (12), 1199-209
    DOI 10.1056/NEJMoa055706, PubMed 16990383

 
Page visits: 6659